[HTML][HTML] An update on psychopharmacological treatment of autism spectrum disorder

R Aishworiya, T Valica, R Hagerman, B Restrepo - Neurotherapeutics, 2022 - Elsevier
While behavioral interventions remain the mainstay of treatment of autism spectrum disorder
(ASD), several potential targeted treatments addressing the underlying neurophysiology of …

Of men and mice: modeling the fragile X syndrome

R Dahlhaus - Frontiers in molecular neuroscience, 2018 - frontiersin.org
The Fragile X Syndrome (FXS) is one of the most common forms of inherited intellectual
disability in all human societies. Caused by the transcriptional silencing of a single gene, the …

Insights into the structure and function of the hippocampus: implications for the pathophysiology and treatment of autism spectrum disorder

J Long, H Li, Y Liu, X Liao, Z Tang, K Han… - Frontiers in …, 2024 - frontiersin.org
The hippocampus is one of the brain areas affected by autism spectrum disorder (ASD).
Individuals with ASD typically have impairments in hippocampus-dependent learning …

Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs

K Roseberry, H Le-Niculescu, DF Levey… - Molecular …, 2023 - nature.com
Anxiety disorders are increasingly prevalent, affect people's ability to do things, and
decrease quality of life. Due to lack of objective tests, they are underdiagnosed and sub …

Cell-type-specific translation profiling reveals a novel strategy for treating fragile X syndrome

SR Thomson, SS Seo, SA Barnes, SR Louros… - Neuron, 2017 - cell.com
Excessive mRNA translation downstream of group I metabotropic glutamate receptors (mGlu
1/5) is a core pathophysiology of fragile X syndrome (FX); however, the differentially …

Unlocking neural function with 3D in vitro models: A technical review of self-assembled, guided, and bioprinted brain organoids and their applications in the study of …

C D'Antoni, L Mautone, C Sanchini, L Tondo… - International Journal of …, 2023 - mdpi.com
Understanding the complexities of the human brain and its associated disorders poses a
significant challenge in neuroscience. Traditional research methods have limitations in …

Molecular mechanisms of synaptic dysregulation in fragile X syndrome and autism spectrum disorders

M Telias - Frontiers in molecular neuroscience, 2019 - frontiersin.org
Fragile X syndrome (FXS) is the most common form of monogenic hereditary cognitive
impairment. FXS patient exhibit a high comorbidity rate with autism spectrum disorders …

Mouse models of fragile X-related disorders

R Willemsen, RF Kooy - Disease Models & Mechanisms, 2023 - journals.biologists.com
The fragile X-related disorders are an important group of hereditary disorders that are
caused by expanded CGG repeats in the 5′ untranslated region of the FMR1 gene or by …

Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome

PK McCamphill, LJ Stoppel, RK Senter… - Science translational …, 2020 - science.org
Fragile X syndrome is caused by FMR1 gene silencing and loss of the encoded fragile X
mental retardation protein (FMRP), which binds to mRNA and regulates translation. Studies …

Excessive proteostasis contributes to pathology in fragile X syndrome

SR Louros, SS Seo, B Maio, C Martinez-Gonzalez… - Neuron, 2023 - cell.com
In fragile X syndrome (FX), the leading monogenic cause of autism, excessive neuronal
protein synthesis is a core pathophysiology; however, an overall increase in protein …